Real‐World Data and Physiologically‐Based Mechanistic Models for Precision Medicine
- 23 February 2020
- journal article
- editorial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 107 (4), 694-696
- https://doi.org/10.1002/cpt.1780
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico StrategyClinical Pharmacology & Therapeutics, 2019
- Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White PaperClinical Pharmacology & Therapeutics, 2019
- Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA MeetingTherapeutic Innovation & Regulatory Science, 2019
- Plasma extracellular nanovesicle (exosome)‐derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposureBritish Journal of Clinical Pharmacology, 2018
- Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulationBritish Journal of Clinical Pharmacology, 2018
- Computational Cardiac Modeling Reveals Mechanisms of Ventricular Arrhythmogenesis in Long QT Syndrome Type 8: CACNA1C R858H Mutation Linked to Ventricular FibrillationFrontiers in Physiology, 2017
- The Autism Speaks Autism Treatment Network Registry Data: Opportunities for InvestigatorsPEDIATRICS, 2016
- Obesity and AutismPediatrics, 2015
- Comorbidity Clusters in Autism Spectrum Disorders: An Electronic Health Record Time-Series AnalysisPEDIATRICS, 2014
- Whole-Heart ModelingCirculation Research, 2011